Postdoctoral Training: Cardiovascular Research Center, Department of Biomedical Engineering, University of Virginia, Charlottesville, VA. 2001
PhD: Department of Cardiology, People's Hospital, Beijing Medical University (Peking University), Beijing, P. R. China. 1998
MS: Department of Cardiology, Qingdao University, Qingdao, P. R. China. 1995
MD: Jining Medical College, Jining, P. R. China. 1989
2020 Distinguished Researcher Award from Augusta University Research Institute, Inc
2020 Distinguished Faculty Award in Basic Science Research, Medical College of Georgia Faculty Senate
2008 Finalist of Irvine H. Page young investigator research award from the arteriosclerosis, thrombosis, and vascular biology annual Conference 2008 (Atlanta, Georgia)
2006 Nominee of the Institute of Medicine Anniversary Fellow from the Medical School of University of Minnesota
2004 Lillehei Scholar Award (2004-2007) from Lillehei Heart Institute at the University of Minnesota
2004 Atorvastatin Research Award (2004–2006) from Pfizer, Inc
2002 Young Investigator Award from the Cardiovascular Section of American Physiological Society
2001 New Investigator Award from American Heart Association
Title: Adenosine receptor 2A in subretinal fibrosis
Type: RO1
Agency: NIH/NEI
Period: 04/27/2022 – 04/30/2027
Role: Principle Investigator
Title: Myeloid PFKFB3 in Subretinal Fibrosis
Type: R01
Agency: NIH/NEI
Period: 04/01/2012 – 04/30/2026
Role: Principle Investigator
Title: VSMC PFKFB3 in atherogenesis
Type: TPA
Agency: AHA
Period: 07/01/2022 – 06/30/25
Role: Principle Investigator
Title: ADK regulation of fat metabolism and insulin sensitivity
Type: R01
Agency: NIDDK
Period: 04/01/2020 – 03/31/24
Role: Co-Investigator
Title: Targeting myeloid glycolysis in pathological ocular angiogenesis
Type: R01
Agency: NEI
Period: 07/01/19 – 06/30/24
Role: Principle Investigator
